Investor Alert

Alexion Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Jan 22, 2021, 7:59 p.m.





-0.73 -0.46%


Volume 195,411

Quotes are delayed by 20 min


Previous close

$ 157.86

$ 159.73


+1.87 +1.18%

Day low

Day high




52 week low

52 week high




Annual Financials for Alexion Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 2.49B3.01B3.52B4.13B4.95B
Cost of Goods Sold (COGS) incl. D&A 350M580M622.2M688.6M704.1M
COGS excluding D&A 189M194M125.5M291.3M327.3M
Depreciation & Amortization Expense 161M386M496.7M397.3M376.8M
Depreciation 44M64M176.6M76.2M61.8M
Amortization of Intangibles 117M322M320.1M321.1M315M
Gross Income 2.14B2.43B2.9B3.44B4.25B
20152016201720182019 5-year trend
SG&A Expense 1.57B1.71B1.95B1.82B2.15B
Research & Development 709M757M862.1M730.3M886M
Other SG&A 863M954M1.08B1.09B1.26B
Other Operating Expense -----
Unusual Expense 145M126M358.5M1.35B9.7M
EBIT after Unusual Expense (145M)594M595.9M271.5M2.09B
Non Operating Income/Expense 119M68M30.7M17.2M86.4M
Non-Operating Interest Income 8M11M18.5M65.3M100.3M
Equity in Affiliates (Pretax) -----
Interest Expense 48M97M97.3M111.8M101.3M
Gross Interest Expense 48M97M97.3M111.8M101.3M
Interest Capitalized -----
Pretax Income 498M576M547.8M242.2M2.18B
Income Tax 354M177M104.5M164.6M(225.5M)
Income Tax - Current Domestic (88M)4M42.9M57M71.8M
Income Tax - Current Foreign 49M69M107.5M74.7M158.2M
Income Tax - Deferred Domestic 389M107M7.2M49.5M1.73B
Income Tax - Deferred Foreign 4M(3M)(53.1M)(16.6M)(2.19B)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 144M399M443.3M77.6M2.4B
Minority Interest Expense -----
Net Income 144M399M443.3M77.6M2.4B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 144M399M443.3M77.6M2.4B
Preferred Dividends -----
Net Income Available to Common 144M399M443.3M77.6M2.4B
EPS (Basic) 0.681.781.980.3510.77
Basic Shares Outstanding 213M224M223.9M222.7M223.2M
EPS (Diluted) 0.671.761.970.3510.70
Diluted Shares Outstanding 216M227M225.4M224.5M224.8M
EBITDA 725M1.11B1.45B2.02B2.48B
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
Powered by StockTwits
Link to MarketWatch's Slice.